219 results on '"Marchou, Bruno"'
Search Results
2. Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae
3. Hematogenous osteomyelitis in childhood can relapse many years later into adulthood: A retrospective multicentric cohort study in France
4. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era
5. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO 16 LYMPHOVIR Cohort
6. Campylobacter fetus foodborne illness outbreak in the elderly.
7. Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease’s lymphadenitis
8. Alveolar and Blood T Lymphocyte Profiles in Pneumocystis jirovecii-Positive Patients: Effects of HIV Status
9. Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib
10. Disseminated osteomyelitis or bone metastases of breast cancer: 18F-FDG-PET/CT helps unravel an unusual presentation
11. Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)
12. Favorable outcome of severe human herpes virus-6 encephalitis in an HIV-infected patient
13. Longitudinal Study of Body Composition of 101 HIV Men With Lipodystrophy: Dual-Energy X-Ray Criteria for Lipodystrophy Evolution
14. Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated immune reconstitution inflammatory syndrome
15. Altered CD[4.sup.+] T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
16. Salmonella enterica serotype Typhi with nonclassical quinolone resistance phenotype
17. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy
18. Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saul, French Guiana
19. Characterization of CXCR4-using HIV-1 during primary infection by ultra-deep pyrosequencing
20. Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence
21. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years
22. High-risk groups for late diagnosis of HIV infection: a need for rethinking testing policy in the general population
23. R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy
24. Frequency of CXCR4-using viruses in primary HIV-1 infections using ultra-deep pyrosequencing
25. Mycobacterial-immune reconstitution inflammatory syndrome: a cause of acute interstitial nephritis during HIV infection
26. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy
27. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature
28. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV
29. CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression
30. Shift in phenotypic susceptibility suggests a competition mechanism in a case of acquired resistance to maraviroc
31. Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease
32. Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management?
33. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism
34. Correlates of late HIV diagnosis: implications for testing policy
35. Intermittent antiretroviral therapy in patients with controlled HIV infection
36. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
37. Early changes in coagulation but not inflammatory biomarkers under intermittent ART: the randomized ANRS 106 WINDOW trial
38. Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen
39. Prospective evaluation of blood Epstein-Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
40. Genotypic prediction of HIV-1 subtype D tropism
41. Evolution of Total and Integrated HIV-1 DNA and Change in DNA Sequences in Patients with Sustained Plasma Virus Suppression
42. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkinʼs lymphoma in relation to CD4 cell number and antibody titres to EBV
43. Development of β-Lactam-Resistant Enterobacter cloacae in Mice
44. A 3-Week Hepatitis B Vaccination Schedule Provides Rapid and Persistent Protective Immunity: A Multicenter, Randomized Trial Comparing Accelerated and Classic Vaccination Schedules
45. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
46. Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis
47. Erratum to ‘Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae’ [International Journal of Antimicrobial Agents 49/1 67–73]
48. Zika virus in semen and spermatozoa
49. HIV-1 Tropism During Primary Infections in France: 1996-2014.
50. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.